Pancreatic plasmacytoma is a rare disorder which may present with obstructive jaundice. Only eighteen cases have been reported in the English language literature. We present the first case of pancreatic plasmacytoma and gastric plasmacytoma diagnosed with endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). A 75-year-old male with a known history of multiple myeloma presented with obstructive jaundice and a pancreatic mass. A concomitant gastric mass due to gastric plasmacytoma was seen. The diagnosis was established via EUS-FNA of the pancreatic mass. Pancreatic plasmacytoma should be suspected in patients with a history of myeloma. EUS-FNA is a safe and effective modality in the diagnosis of pancreatic plasmacytoma. Radiation therapy should be the first-line of therapy in treating pancreatic plasmacytomas.
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Introduction
Extramedullary plasmacytomas consist of neoplastic plasma cell proliferation that occurs outside the bone marrow. Extraskeletal plasmacytomas are infrequent, occurring in fewer than 5% of plasma cell neoplasms [1] . Pancreatic plasmacytomas are rare, with only eighteen cases identified in the English language literature. Endoscopic ultrasound provides detailed imaging of the pancreas and accurate fine needle aspiration tissue sampling [2] . We describe a case of concomitant pancreatic and gastric plasmacytoma diagnosed with endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of the pancreas and endoscopic biopsy of the stomach in a patient with multiple myeloma.
Case Report
A 75-year-old male with a 10-year history of multiple myeloma treated with chemotherapy and radiation therapy presented with three weeks of progressive fatigue and jaundice. His past medical history included coronary artery disease, peripheral neuropathy and deep venous thrombosis. Physical exam revealed icteric sclerae and a normal abdominal examination. Laboratory studies revealed anemia with a hemoglobin of 8.2 g/dl and an obstructive liver enzyme pattern with a total bilirubin of 6.9 mg/dl, alkaline phosphatase of 347 U/l and ALT of 528 U/l. Abdominal ultrasound identified a 5.3 cm focal lesion arising from the head/proximal body of the pancreas, with a lobular contour and inhomogenous texture. The common bile duct was dilated to 2 cm. Fascial and maxillary computed tomography scan was unremarkable.
Upper endoscopy (esophagogastroduodenoscopy) identified a 4 cm gastric mass with a large adherent blood clot, located in the proximal body along the greater curvature, with overlying ulceration ( fig. 1) . Forceps biopsies were obtained from the edge of the gastric mass. Pathology revealed reactive gastric glands surrounded by a dense, diffuse infiltrate of plasmacytoid cells ( fig. 2 ). These cells were characterized by a moderate amount of amphophilic cytoplasm and eccentric nuclei with scattered nuclear pleomorphism. Although many cells displayed a mature plasma cell phenotype, others appeared immature. The differential diagnosis included lymphocytic gastritis related to Helicobacter pylori, plasma cell-rich mucosa-associated lymphoid tissue (MALT)-type lymphoma, and plasmacytoma. Immunostain for Helicobacter species was negative, Mum1 (a myeloma-associated oncogene), kappa light chain and CD138 immunostains were positive, while lambda light chain stains were negative, consistent with involvement by the patient's multiple myeloma.
Linear endoscopic ultrasound examination (GFUCT-140, Olympus America, Center Valley, Pa., USA) identified a 4 × 5 cm hypoechoic, heterogenous mass in the head of the pancreas obstructing the bile duct ( fig. 3) . The bile duct measured 2 cm with some sludge within the duct. The pancreatic duct was not obstructed by the mass (measuring 1.8 mm in the body) and the pancreatic parenchyma in the body and tail was normal. No enlarged peripancreatic or celiac lymph nodes were seen. The 5 × 4 cm gastric mass had a similar sonographic appearance and was seen to abut the spleen. EUS-FNA of the pancreatic and gastric mass was performed. Both sites revealed a predominant monomorphic population of plasma cells, which were dispersed as single cells. The cells had round to oval eccentric nuclei, nuclear membrane irregularity, occasional prominent nucleoli and a fine to coarsely clumped chromatin pattern. The cytoplasm was abundant and basophilic, with a perinuclear clear zone. These cytologic features were consistent with plasmacytoma ( fig. 4) .
The aspirated material obtained from the head of the pancreas was also sent for flow cytometry. Flow cytometry showed more than 60% of the cells to be positive for CD45 dim, CD38, and were cyto-kappa-restricted, confirming the diagnosis of plasmacytoma. The patient was treated with radiation therapy, which resulted in improvement of liver function tests. Six months later his liver enzymes remained normal and repeat imaging studies of the pancreas showed resolution of the pancreatic plasmacytoma.
Discussion
Plasmacytoma is an immunoproliferative monoclonal disorder of plasma cells that usually affects the bone marrow. Extramedullary plasmacytomas involve soft tissue organs outside the bone marrow and represent 3-4% of all plasma cell neoplasms. Plasmacytomas may be primary (in the absence of multiple myeloma of the bone marrow) or secondary (in the presence of multiple myeloma of the bone marrow) [3] .
Plasmacytomas are composed of plasma cells of variable maturity, which are histologically analogous to those seen in multiple myeloma. The median age of presentation of extramedullary plasmacytomas is 55 years (10 years younger than patients with multiple myeloma) and the majority (three-fourths) are male [4] . The upper respiratory tract (oronasopharynx and paranasal sinuses) is the most common site (80%) of extramedullary plasmacytomas [5] . Approximately 10% of extramedullary plasmacytomas occur in the gastrointestinal tract, the stomach being the most frequent site [6] .
The diagnosis of an extramedullary plasmacytoma depends on the demonstration of a monoclonal plasma cell tumor outside the bone marrow. Poorly differentiated pancreatic neoplasms and lymphoma may be difficult to differentiate from plasmacytomas; immunohistochemistry and flow cytometry play key roles in diagnosis. In our case, immunohistochemistry was performed on an endoscopic mucosal biopsy of the stomach and flow cytometry on EUS-FNA of the pancreas. In rare cases, extramedullary plasmacytoma may represent a marginal zone B-cell lymphoma that has undergone an extensive degree of plasmacytic differentiation, which signifies a worse prognosis [7] . Extramedullary gastric plasmacytomas may further cause a diagnostic dilemma in the differentiation from MALT-type lymphoma. The absence of morphologic criteria of gastric MALT including centrocyte-like cells, lymphoepithelial lesions, reactive follicles and absence of B-lymphocyte antigens (CD45 and CD20) helps in the differentiation [8] .
It is very difficult to radiologically differentiate extramedullary plasmacytoma of the pancreas from other pancreatic tumors, especially those which show enhancement with intravenous contrast such as endocrine cell tumors and acinar cell neoplasms [9] . Sonographically, pancreatic plasmacytomas appear as hypoechoic, homogenous masses, well demarcated from the surrounding normal pancreatic parenchyma. This is the first case report of EUS-FNA confirming the diagnosis of a pancreas plasmacytoma. Diagnosis has been obtained in prior reports via percutaneous biopsy or laparotomy [3, 10] . As demonstrated in this case, EUS-FNA may also provide adequate material for flow cytometry analysis [11] .
The management of patients with extramedullary plasmacytoma may include radiation therapy, surgery, or combination therapy (surgery and/or chemotherapy or radiation) [12, 13] . Plasma cell tumors are highly sensitive to radiation therapy. Solitary plasmacytoma of the tail of the pancreas can also be managed by distal pancreatectomy in good surgical candidates [14] . Patients with extramedullary plasmactyoma who had combined surgery and radiation therapy had a median survival 25 years greater than those who had only surgical intervention (13 years) or only radiation therapy (12 years) [12] .
Conclusion
In summary, we report a rare case of concomitant extramedullary gastric and pancreatic plasmacytoma which is the first report of pancreatic plasmacytoma diagnosed with EUS-FNA. Extramedullary plasmacytoma should be considered in the differential diagnosis in patients with multiple myeloma presenting with a pancreatic mass and/or obstructive jaundice.
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